These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 33306497)

  • 1. Polycystic Ovarian Syndrome Genetics and Epigenetics.
    Combs JC; Hill MJ; Decherney AH
    Clin Obstet Gynecol; 2021 Mar; 64(1):20-25. PubMed ID: 33306497
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Epigenetics of polycystic ovary syndrome].
    Concha C F; Sir P T; Recabarren SE; Pérez B F
    Rev Med Chil; 2017 Jul; 145(7):907-915. PubMed ID: 29182200
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epigenetic Marks in Polycystic Ovary Syndrome.
    Motta AB
    Curr Med Chem; 2020; 27(39):6727-6743. PubMed ID: 31580245
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polycystic Ovary Syndrome-Epigenetic Mechanisms and Aberrant MicroRNA.
    Ilie IR; Georgescu CE
    Adv Clin Chem; 2015; 71():25-45. PubMed ID: 26411410
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polycystic Ovary Syndrome: the Epigenetics Behind the Disease.
    Eiras MC; Pinheiro DP; Romcy KAM; Ferriani RA; Reis RMD; Furtado CLM
    Reprod Sci; 2022 Mar; 29(3):680-694. PubMed ID: 33826098
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of epigenetic interactions between microRNA and DNA methylation associated with polycystic ovarian syndrome.
    Mao Z; Li T; Zhao H; Qin Y; Wang X; Kang Y
    J Hum Genet; 2021 Feb; 66(2):123-137. PubMed ID: 32759991
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DNA methylation in polycystic ovary syndrome: Emerging evidence and challenges.
    Liu YN; Qin Y; Wu B; Peng H; Li M; Luo H; Liu LL
    Reprod Toxicol; 2022 Aug; 111():11-19. PubMed ID: 35562068
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DNA methylation in the pathogenesis of polycystic ovary syndrome.
    Vázquez-Martínez ER; Gómez-Viais YI; García-Gómez E; Reyes-Mayoral C; Reyes-Muñoz E; Camacho-Arroyo I; Cerbón M
    Reproduction; 2019 Jul; 158(1):R27-R40. PubMed ID: 30959484
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epigenetics in polycystic ovary syndrome: a pilot study of global DNA methylation.
    Xu N; Azziz R; Goodarzi MO
    Fertil Steril; 2010 Jul; 94(2):781-3.e1. PubMed ID: 19939367
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic and epigenetic characteristics in ovarian tissues from polycystic ovary syndrome patients with irregular menstruation resemble those of ovarian cancer.
    Jiao J; Sagnelli M; Shi B; Fang Y; Shen Z; Tang T; Dong B; Li D; Wang X
    BMC Endocr Disord; 2019 Mar; 19(1):30. PubMed ID: 30866919
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Genetic and epigenetic factors of polycystic ovary syndrome].
    Herczeg Z; Vanya M; Szili K; Dézsi C; Nagy Z; Szabó J
    Orv Hetil; 2016 Aug; 157(32):1275-81. PubMed ID: 27499286
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DNA methylome profiling of granulosa cells reveals altered methylation in genes regulating vital ovarian functions in polycystic ovary syndrome.
    Sagvekar P; Kumar P; Mangoli V; Desai S; Mukherjee S
    Clin Epigenetics; 2019 Apr; 11(1):61. PubMed ID: 30975191
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epigenetic association analysis of clinical sub-phenotypes in patients with polycystic ovary syndrome (PCOS).
    Jacobsen VM; Li S; Wang A; Zhu D; Liu M; Thomassen M; Kruse T; Tan Q
    Gynecol Endocrinol; 2019 Aug; 35(8):691-694. PubMed ID: 30782033
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deciphering the DNA Methylome of Polycystic Ovary Syndrome.
    Tan Q
    Mol Diagn Ther; 2020 Jun; 24(3):245-250. PubMed ID: 32297305
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genome-wide methylation profiling in granulosa lutein cells of women with polycystic ovary syndrome (PCOS).
    Makrinou E; Drong AW; Christopoulos G; Lerner A; Chapa-Chorda I; Karaderi T; Lavery S; Hardy K; Lindgren CM; Franks S
    Mol Cell Endocrinol; 2020 Jan; 500():110611. PubMed ID: 31600550
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Role of Genetics, Epigenetics and Lifestyle in Polycystic Ovary Syndrome Development: the State of the Art.
    Bruni V; Capozzi A; Lello S
    Reprod Sci; 2022 Mar; 29(3):668-679. PubMed ID: 33709373
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Introduction: Determinants of polycystic ovary syndrome.
    Azziz R
    Fertil Steril; 2016 Jul; 106(1):4-5. PubMed ID: 27238627
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential DNA methylation patterns of polycystic ovarian syndrome in whole blood of Chinese women.
    Li S; Zhu D; Duan H; Ren A; Glintborg D; Andersen M; Skov V; Thomassen M; Kruse T; Tan Q
    Oncotarget; 2017 Mar; 8(13):20656-20666. PubMed ID: 27192117
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transcriptional and Epigenetic Changes Influencing Skeletal Muscle Metabolism in Women With Polycystic Ovary Syndrome.
    Nilsson E; Benrick A; Kokosar M; Krook A; Lindgren E; Källman T; Martis MM; Højlund K; Ling C; Stener-Victorin E
    J Clin Endocrinol Metab; 2018 Dec; 103(12):4465-4477. PubMed ID: 30113663
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epigenetic regulation of an adverse metabolic phenotype in polycystic ovary syndrome: the impact of the leukocyte methylation of PPARGC1A promoter.
    Zhao H; Zhao Y; Ren Y; Li M; Li T; Li R; Yu Y; Qiao J
    Fertil Steril; 2017 Feb; 107(2):467-474.e5. PubMed ID: 27889100
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.